NoneNo Change
Cardiac Function
Metformin → Cardiac Function
Metformin → Cardiac Function
Evidence profile
NoneNo ChangeClinical Outcomes
Unlock full evidence details
Research Summary
Analyzed using Evidence Intelligence™
Metformin improves glycemic control in heart failure patients
Key finding
Insulin sensitivity improved significantly with metformin treatment.
Metformin therapy in adults with heart failure and type 2 diabetes.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Some Concerns bias
Last updated July 4, 2026Quick read
Study at a glance
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Metformin
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Primary outcome
Insulin sensitivity (MCR)
Comparator
Placebo
Plain-language summary
What this paper says
A plain-language read of the study's main message and where it applies.
Study focus
Metformin therapy in adults with heart failure and type 2 diabetes.
Clinical relevance
This study evaluated Metformin therapy in adults with heart failure and type 2 diabetes.
Keep in mind
Limitations were not clearly described in the extracted text.
Published in
Journal Reference
Publication details and source links for this paper.
Vojtěch M, Eva H, Kateřina V, et al. Metformin Improves Glycemic Control in Patients with Heart Failure and Type 2 Diabetes. Clinical Diabetes : A Publication of the American Diabetes Association. 2025;43(1):23-32. doi:10.2337/cd24-0003
Save this study and add notes to your research library.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Metformin and Cardiac Function, Glucose iAUC (OGTT), HbA1c, and 2 more.
This study contributes evidence to
Primary intervention
Metformin
Primary outcomes
- Cardiac Function
- Glucose iAUC (OGTT)
- HbA1c
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
5
Evidence pairs
5
Relationships
5
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
5
Related topics
5
Evidence pairs
490
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 5 evidence relationships
- Includes primary outcome data
- Linked to 5 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
Study findings
The primary outcomes reported in this study.
StrongDecrease
Glucose iAUC (OGTT)
Metformin → Glucose iAUC (OGTT)
Metformin → Glucose iAUC (OGTT)
Evidence profile
StrongDecreaseGlycemic Control
Unlock full evidence details
StrongDecrease
HbA1c
Metformin → HbA1c
Metformin → HbA1c
Evidence profile
StrongDecreaseGlycemic Control
Unlock full evidence details
StrongIncrease
Insulin sensitivity
Metformin → Insulin sensitivity
Metformin → Insulin sensitivity
Evidence profile
StrongIncreaseMetabolic Health
Unlock full evidence details
NoneNo Change
Trimethylamine N-oxide (TMAO)
Metformin → Trimethylamine N-oxide (TMAO)
Metformin → Trimethylamine N-oxide (TMAO)
Evidence profile
NoneNo ChangeMetabolic Health
Unlock full evidence details
Unlock full evidence analysis
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Already have an account?
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Metformin Therapies and HbA1c, Metformin Therapies and Postprandial and OGTT Glucose.
Related evidence relationships
Explore in Evidence ArchiveThis study contributes to the evidence on the following intervention-outcome relationships.
Included in these evidence collections
Curated evidence collections and hubs this study is part of.
HbA1c Evidence Hub
All studies measuring HbA1c
7 studies
outcome_hubMeasures HbA1c as a key outcome.
Metformin Therapies Evidence Hub
All studies on Metformin Therapies
7 studies
intervention_hubContributes to Metformin Therapies evidence base.
Postprandial and OGTT Glucose Evidence Hub
All studies measuring Postprandial and OGTT Glucose
1 studies
outcome_hubMeasures Postprandial and OGTT Glucose as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explore more in the evidence archive
Jump to pre-filtered views in the evidence archive.
All studies on Metformin and HbA1c
Intervention: MetforminOutcome: HbA1c
7 results
All studies on Metformin and Glucose iAUC (OGTT)
Intervention: MetforminOutcome: Glucose iAUC (OGTT)
1 results
All studies on Metformin
Intervention: Metformin
7 results
All studies measuring HbA1c
Outcome: HbA1c
7 results
All studies measuring Glucose iAUC (OGTT)
Outcome: Glucose iAUC (OGTT)
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Metformin Therapies improve HbA1c?
Emerging Evidence
Metformin Therapies may improve HbA1c.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Moderate | EvidenceScore™ 61.9 | moderate positive | ConsensusScore™ Consistent | 1 study
Why this answer: This answer is based on 8 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Metformin Therapies improve postprandial and ogtt glucose?
Emerging Evidence
Metformin Therapies appears to improve Postprandial and OGTT Glucose.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Glucose iAUC (OGTT)
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
- Only a small number of supporting studies are available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Metformin Therapies improve insulin resistance?
Emerging Evidence
Current evidence does not show a clear benefit of Metformin Therapies for Insulin Resistance.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Insulin sensitivity
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on 3 supporting studies and existing graph evidence signals.
Limitations
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Metformin improve cardiac function?
Limited Evidence
Current evidence does not show a clear benefit of Metformin for Cardiac Function.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Cardiac Function
EvidenceScore™ Limited | EvidenceScore™ 34.2 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, archive views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in archive
Open broader archive views for this relationship.
Related research
Read related research summaries.
Early use of effective therapies may improve diabetes outcomesSitagliptin with Metformin Improves Metabolic HealthMetformin and Liraglutide Improve Gut Microbiome in Youth with DiabetesNewer diabetes drugs show stronger weight and blood sugar benefits in prediabetesGLP-1 agonists reduce heart fat thickness in diabetes.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.